CAS No. 1208319-27-0

Molecular Formula: C19H27N5O6S
Molecular Weight: 453.51258

Purity: 98% min
Application: Used for controlling pruritus associated with allergic dermatitis in dogs.
Synonyms: Oclacitinib Maleate

EINECS:200-001-8
Molecular formula:C19H27N5O6S

Molecular Weight: 337.44 (free base)
Molecular Formula: C15H23N5O2S.xC4H4O4
Purity: ≥95%
Solubility: Soluble in DMSO (Slightly), Methanol (Slightly, Sonicated)
Storage: Store at -20°C under inert atmosphere
Synonyms: Cyclohexanemethanesulfonamide, N-methyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-, trans-, (2Z)-2-butenedioate (1:x); Apoquel; Oclacitinib maleate (1:x); PF 03394197-11; trans-N-Methyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclohexanemethanesulfonamide maleate (1:x); N-methyl-1-((1r,4r)-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide maleate
Description
Oclacitinib maleate was the first selective Janus kinase (JAK) inhibitor to be developed for dogs. Oclacitinib is most potent at inhibiting JAK1 (IC50=10 nM).


More details are to be found on supplier website